Cure of cryptococcal infection during continued immunosuppressive therapy

A. J. Watson, R. P. Russell, R. F. Cabreja, R. Braverman, A. Whelton

Research output: Contribution to journalArticle


Cryptococcus neoformans is a significant pathogen in immunosuppressed patients. In renal transplant recipients receiving prednisone, the development of cryptococcosis is associated with a poor prognosis. When such patients develop cryptococcosis they pose a particularly difficult clinical dilemma since withdrawal of prednisone, to facilitate cure of their fungal infection, may predispose to loss of their transplanted kidney. We report our experience with cryptococcal infection in 13 renal transplant patients. In 11 of these patients maintenance immunosuppres-sion was cautiously continued to preserve allograft function. The results of our study suggest that maintenance immunosuppressive therapy may be continued throughout the period of anti-fungal therapy and does not preclude eradication of the infecting organisms. Our experience indicates that the prognosis for the renal transplant patient who has cryptococcosis can be improved.

Original languageEnglish (US)
Pages (from-to)169-172
Number of pages4
Issue number2
StatePublished - 1985

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Cure of cryptococcal infection during continued immunosuppressive therapy'. Together they form a unique fingerprint.

  • Cite this

    Watson, A. J., Russell, R. P., Cabreja, R. F., Braverman, R., & Whelton, A. (1985). Cure of cryptococcal infection during continued immunosuppressive therapy. QJM, 55(2), 169-172.